VS
stockvs
Go to ScreenerHub
JNJ

JNJ vs NVS

NVS

In the past 12 months, JNJ returned +49% while NVS gained 38%.

JNJ
JNJ

Johnson & Johnson

$243.19
-0.1%(1M)
Market Cap586.1B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio22.08
ROE33.8%
P/B Ratio7.26
Dividend Yield2.1%
NVS
NVS

Novartis AG

$154.87
-6.8%(1M)
Market Cap299.4B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio21.34
ROE32.8%
P/B Ratio6.48
Dividend Yield3.0%
Performance Comparison

Historical returns across multiple timeframes

JNJ leads 5/8
JNJ

JNJ

Johnson & Johnson

+49.3%

1Y Return

NVS

NVS

Novartis AG

+38.0%

1Y Return

JNJ
JNJ
NVS
NVS

Short Term

1M-6M

JNJ
+18.0%

Medium Term

YTD-1Y

JNJ
+33.3%

Long Term

3Y-10Y

NVS
+113.5%

Valuation

Compare price multiples and valuation ratios

JNJ: 0NVS: 5
MetricJNJNVSWinner
P/E Ratio

Price to earnings ratio

22.0821.34NVS
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.245.30NVS
P/B Ratio

Price to book ratio

7.266.48NVS
P/FCF Ratio

Price to free cash flow ratio

29.8217.78NVS
EV/EBITDA

Enterprise value to EBITDA

15.3614.15NVS
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

JNJ: 3NVS: 3
MetricJNJNVSWinner
Gross Margin

Gross profit margin

72.8%75.7%NVS
Operating Margin

Operating profit margin

27.2%31.2%NVS
Net Margin

Net profit margin

28.5%24.9%JNJ
ROE

Return on equity

33.8%32.8%JNJ
ROA

Return on assets

13.5%12.1%JNJ
ROIC

Return on invested capital

13.7%16.0%NVS

Growth

Compare revenue and earnings growth rates

JNJ: 3NVS: 3
MetricJNJNVSWinner
Revenue Growth (YoY)

Year-over-year revenue growth

6.0%6.0%JNJ
Revenue Growth (3Y)

3-year revenue CAGR

5.6%8.0%NVS
Revenue Growth (5Y)

5-year revenue CAGR

2.7%1.9%JNJ
EPS Growth (YoY)

Year-over-year EPS growth

90.5%22.5%JNJ
EPS Growth (3Y)

3-year EPS CAGR

17.9%31.4%NVS
EPS Growth (5Y)

5-year EPS CAGR

14.9%15.4%NVS

Balance Sheet & Risk

Compare financial stability and debt levels

JNJ: 3NVS: 2
MetricJNJNVSWinner
Debt/Equity

Debt to equity ratio

0.590.80JNJ
Current Ratio

Current assets to current liabilities

1.031.12NVS
Quick Ratio

Quick assets to current liabilities

0.770.89NVS
Interest Coverage

EBIT to interest expense

26.3615.13JNJ
Beta

Stock volatility vs market

0.330.50JNJ
Summary

Valuation

NVS

Profitability

Tie

Growth

Tie

Balance Sheet

JNJ

NVS is more attractively valued. JNJ has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into JNJ and NVS with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/JNJ/vs/NVS" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare JNJ vs NVS on stockvs.app
</a>